1-acyldihydropyrazole derivatives

Details 1-acyldihydropyrazole derivatives 1-acyldihydropyrazole derivatives

2011-01-25

2011-01-25

Chu, Yong (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S444000, C514S367000, C514S269000, C514S360000, C514S266200, C514S231500, C544S284000, C544S238000, C544S111000, C544S132000, C548S126000, C548S304700, C548S156000, C549S059000

Reexamination Certificate

active

07875644

ABSTRACT:
Compounds of the formula (I), in which R1, R2, R3a, R3b, R3cand R3dhave the meanings indicated in claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for the treatment of tumours.

REFERENCES:
patent: 0 537 580 (1993-04-01), None
patent: WO 01/32173 (2001-05-01), None
patent: WO 03/079973 (2003-10-01), None
Cited—ref—STN—preliminary—12063925.
Vippagunta et al., Advanced Drug Delivery Reviews, 2001, p. 3.
STN—12063925—10082009.
STN—12063925A—10082009.
STN—12063925A—part 2—10082009.
Nabeya et al. J. Org. Chem., vol. 35(6), 1970, p. 2023-4.
CAS Registry No. 312607-55-9.
CAS Registry No. 350707-73-2.

Affiliated with

Also associated with

Rating

1-acyldihydropyrazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1-acyldihydropyrazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-acyldihydropyrazole derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2701926